Resource Center
Find the latest content and resources from our team of experts to keep you in the know for all things quality and regulatory in the life science industry.
Sort by topic
Sort by resource type
The European regulatory landscape continues to evolve rapidly, with new initiatives aimed at balancing innovation, ...
The U.S. Food and Drug Administration (FDA) announced it will not accept regulatory submissions that require user ...
EMMA International proudly announces the launch of its new Financial Services for Life Science Companies. This ...
For decades, ready-to-eat cereals have been marketed as the cornerstone of a “healthy breakfast.” Bright ...
Generic drugs remain essential for healthcare systems worldwide, but evolving formulations, delivery systems, and ...
Clinical trial results shape how physicians treat patients and how new therapies enter the market. But recent ...
The European regulatory landscape is shifting quickly, with new proposals and updates designed to strengthen ...
The U.S. Food and Drug Administration (FDA) continues to advance its Real-World Evidence (RWE) Program, designed ...
In the high-stakes world of pharmaceuticals and life sciences, regulatory submissions are the final gateway ...
Artificial intelligence (AI) continues to reshape how clinical research is conducted, and a new framework called ...
Ensuring patients have access to the most accurate and up-to-date safety information is one of the FDA’s highest ...
Recent research suggests that artificial and low-/no-calorie sweeteners (LNCSs) might not be as harmless as many ...
No results found.